Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-28EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.
The EMA authorizes Mounjaro (tirzepatide) for therapeutic use in type 2 diabetes, obesity, and overweight conditions.
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
A completed clinical trial investigating renal hemodynamics, energetics, and insulin resistance in subjects with type 2 diabetes, with resul…
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Results: A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing oral semaglutide to a dummy comparator in children and teenagers with type 2 diabetes has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Results: Home Food Delivery for Diabetes Management in Patients of Rural Clinics [NA]
Completed clinical trial evaluating home food delivery for diabetes management in rural clinics; results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-19Clinical Trial Results: Embedded Primary Care MultiDisciplinary Diabetes Clinic [NA]
Completed results for a primary care multidisciplinary diabetes clinic trial sponsored by Emory University.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-08-18EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.
EMA authorised Mounjaro (tirzepatide) for therapeutic use in type 2 diabetes mellitus, obesity, and overweight conditions.
-
CLINICAL_TRIALS research · 2026-08-17Clinical Trial Results: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes
A completed clinical trial examines pre-diagnosis GLP-1 receptor agonist use and post-cancer mortality in adults with obesity and type 2 dia…
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Update: A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes [Phase 3]
A Phase 3 trial assessing two oral semaglutide formulations for safety and efficacy in reducing blood glucose in Japanese adults with Type 2…
-
FDA approval · 2026-08-11FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
Supplemental application for JANUMET (sitagliptin and metformin HCl) submitted by Merck to FDA for a label-related or indication-related cha…
-
FDA approval · 2026-08-11FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA supplemental application approval for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Laurus Labs Limited)
FDA supplemental application approval for Metformin Hydrochloride (generic) by Laurus Labs Limited.
-
FDA approval · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA supplemental approval for Metformin Hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2026-08-11FDA Approved: FORTAMET — Supplemental Application (ANDRX LABS LLC)
Supplemental application approval for Fortamet (metformin hydrochloride) by Andrx Labs LLC.
-
FDA approval · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA supplemental approval for Metformin Hydrochloride by Amneal Pharmaceuticals LLC.
-
FDA label_change · 2026-08-11FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA supplemental approval for Glipizide and Metformin hydrochloride combination product (Zydus Pharmaceuticals USA Inc.).
-
FDA label_change · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
A supplemental application for metformin hydrochloride was approved, typically reflecting a formulation change, labeling update, or manufact…
-
FDA approval · 2026-08-11FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (NOVITIUM PHARMA)
Supplemental approval for a combination product containing glipizide and metformin hydrochloride by Novitium Pharma.
-
FDA approval · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (IPCA LABS LTD)
FDA approves a supplemental application for metformin hydrochloride from IPCA Labs Ltd.
-
FDA approval · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE ORAL SOLUTION — Supplemental Application (TRUPHARMA, LLC)
Supplemental application approval for Metformin Hydrochloride Oral Solution by Trupharm a, LLC to support a new or revised formulation and/o…
-
FDA label_change · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (ALIGNSCIENCE PHARMA)
FDA supplemental application for metformin hydrochloride submitted by AlignScience Pharma; indicates a label change or addition related to a…
-
FDA approval · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (ACTAVIS ELIZABETH)
Supplemental application approval for Metformin Hydrochloride by Actavis Elizabeth.
-
FDA approval · 2026-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approves a supplemental application for metformin hydrochloride extended-release tablets from ScieGen Pharmaceuticals, Inc., signaling a…
-
CLINICAL_TRIALS trial_result · 2026-08-10Clinical Trial Results: A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) [Phase 4]
Phase 4 trial comparing RYBELSUS to other blood sugar–lowering tablets in adults with type 2 diabetes; results posted after completion.
-
FDA label_change · 2026-08-07FDA Approved: REPAGLINIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
Supplemental approval for REPAGLINIDE filed by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Michigan Men's Diabetes Project 2 [NA]
A completed clinical trial from the University of Michigan evaluating a diabetes-focused intervention (Type 2 diabetes). Results posted as o…